The Centre For Doctoral Training (CDT) affiliated with the EPSRC Centre For Innovative Manufacturing In Emergent Macromolecular Therapies (CIMEMT) was established in May 2012. New funding was awarded in 2014 by the EPSRC for a further four cohorts (starting 2015-2018). Its focus is on manufacturing research and training required in the most rapidly developing parts of the UK bio-centred pharmaceutical and healthcare biotechnology sector, that have major implications for future medicine.
Our aim is to train bioprocess engineering leaders of the future who will underpin translation of new scientific advances into safely produced, more selective, therapies for currently intractable conditions at affordable costs. To achieve this we embed CDT PhD students within the vibrant research community of the top UK Institutions and that of the EPSRC CIMEMT. Regular presentation to the industrial partners, and attendance of CIMEMT networking events, ensures that CDT students benefit from increased impact and knowledge transfer of their research, as well as access to relevant career opportunities.
All projects involve collaboration with the CIMEMT and are required to have a strategic plan to develop this collaboration. A key aim of the CDT is to capture novel analytical, mathematical, computational and predictive techniques, emerging from academic laboratories across the UK, and bring them to bear on the EPSRC Centre vision. We support CDT PhDs to establish blue-sky collaborations with academics whose underpinning research areas will in time directly bear upon bioprocess manufacturing. Up to 70% of the CDT cohort is either based at, or directly collaborating with internationally leading external Institutes. Seven PhDs a year will be funded by the CDT until 2018, while the CDT programme also attracts an additional three to four overseas students each year funded by international agencies.
To discuss potential research projects that could be supported by the CDT please contact Professor Paul Dalby.